Related Experiment Video
Updated: Mar 27, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Physics-based machine learning for enhanced drug formulation development
Hao Zhong1, Ping Xiong1, Nannan Wang1
1State Key Laboratory of Mechanism and Quality of Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau 999078, China.
Abstract:
Formulation design is constrained by scarce and heterogeneous experimental data, which limits the accuracy and generalizability of conventional AI models. Here, we introduce a physics-based machine learning (PBML) approach that integrates physics-based modeling with data-driven learning to improve drug formulation development. Our approach predicts key formulation properties across two different systems, including physical stability of amorphous solid dispersions (ASDs) and molecular hygroscopicity. For ASDs, molecular dynamics (MD)-derived descriptors that explicitly encode non-covalent interactions (drug-polymer interaction energies, hydrogen-bond networks) and mobility (diffusion coefficients) markedly outperform empirical experimental parameters on the same dataset, improving generalization to unseen APIs under grouped cross-validation (75.2% vs. 66.1%). For hygroscopicity, hygroscopic/nonhygroscopic labels were first assigned based on MD simulation results. A classification model was then trained using these MD-derived labels and validated to have strong performance on external experimental datasets (accuracy = 0.967; F1-score = 0.957; AUC-ROC = 0.931). Across both systems, the synergy between MD-derived descriptors and Tabular Prior-data Fitted Network (TabPFN) performs well on limited formulation datasets. In addition, SHapley Additive exPlanations (SHAP) analyses align feature importance with known experimental mechanisms. For instance, stronger drug-polymer attraction and lower API mobility stabilize ASDs, while higher surface polarity and electrostatic potential (ESP) variance drive hygroscopicity, thereby improving interpretability at the representation level. Overall, our PBML framework provides a data-efficient and mechanism-grounded approach that can enhance decision-making in formulation design. This approach has the potential to extend the utility of limited datasets in drug formulation design and to reduce experimental burden.
Related Concept Videos
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Biopharmaceutics and Pharmacokinetics: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
